Massachusetts biotech industry rebounds strongly in 2026 after employment decline
Massachusetts' biopharmaceutical sector experienced its first employment decline since 2002 last year, but 2026 has seen a significant recovery. The turnaround is attributed to renewed investment and pipeline activity. The sector's growth is a positive sign for the state's economy.
Related stories
Sanofi trims Massachusetts workforce by 229 after Blueprint purchase · Healthcare systems
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026.” Browse more stories.